Patents by Inventor Tom Bretschneider

Tom Bretschneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDAZINES
    Publication number: 20230100516
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 30, 2023
    Inventors: Christian Andreas Kuttruff, Tom Bretschneider, Cédrickx Godbout, Hannes Fiepko Koolman, Domnic Martyres, Gerald Juergen Roth
  • NOVEL PYRIDAZINES
    Publication number: 20230022770
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Application
    Filed: August 30, 2022
    Publication date: January 26, 2023
    Inventors: Christian Andreas KUTTRUFF, Tom BRETSCHNEIDER, Cédrickx GODBOUT, Hannes Fiepko KOOLMAN, Domnic MARTYRES, Gerald Juergen ROTH
  • N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators
    Patent number: 11485727
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by autotaxin.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: November 1, 2022
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Andreas Kuttruff, Tom Bretschneider, Cédrickx Godbout, Hannes Fiepko Koolman, Domnic Martyres, Gerald Juergen Roth
  • Pyridazines
    Patent number: 11465982
    Abstract: The present invention relates to novel pyridazines of the below formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by autotaxin:
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: October 11, 2022
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Christian Andreas Kuttruff, Tom Bretschneider, Cédrickx Godbout, Hannes Fiepko Koolman, Domnic Martyres, Gerald Juergen Roth
  • Pyridazines
    Patent number: 11104665
    Abstract: The present invention relates to novel pyridazines according to formula (I) processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: August 31, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Gerald Juergen Roth, Tom Bretschneider, Christian Andreas Kuttruff
  • NOVEL PYRIDAZINES
    Publication number: 20210024495
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Application
    Filed: July 20, 2020
    Publication date: January 28, 2021
    Inventors: Christian Andreas KUTTRUFF, Tom BRETSCHNEIDER, Cédrickx GODBOUT, Hannes Fiepko KOOLMAN, Domnic MARTYRES, Gerald Juergen ROTH
  • NOVEL PYRIDAZINES
    Publication number: 20210024492
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Application
    Filed: July 20, 2020
    Publication date: January 28, 2021
    Inventors: Christian Andreas KUTTRUFF, Tom BRETSCHNEIDER, Cédrickx GODBOUT, Hannes Fiepko KOOLMAN, Domnic MARTYRES, Gerald Juergen ROTH
  • NOVEL PYRIDAZINES
    Publication number: 20200131151
    Abstract: The present invention relates to novel pyridazines, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of diseases and disorders mediated by Autotaxin.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 30, 2020
    Inventors: Gerald Juergen ROTH, Tom BRETSCHNEIDER, Christian Andreas KUTTRUFF
  • Chartreusin analogues
    Patent number: 9522930
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: December 20, 2016
    Assignee: LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae
  • JAGARICIN DERIVATIVES AND THEIR USE AS FUNGICIDE OR ANTITUMOR AGENT
    Publication number: 20150210741
    Abstract: This invention concerns a novel compound termed jagaricin, jagaricin derivatives, pharmaceutical compositions comprising these compounds, a method for producing jagaricin, and the use of the novel compound as fungicide or antitumor agent.
    Type: Application
    Filed: August 22, 2013
    Publication date: July 30, 2015
    Inventors: Tom Bretschneider, Katharina Graupner, Christian Hertweck, Gerald Lackner, Kirstin Scherlach
  • NOVEL CHARTREUSIN ANALOGUES
    Publication number: 20150197539
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: July 30, 2013
    Publication date: July 16, 2015
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae